방영학 (울산대학교 의과대학, 서울아산병원 종양내과, 삼성융합의과학원)님 | 한빛사연구자 > 한빛사

울산대학교 의과대학, 서울아산병원 종양내과, 삼성융합의과학원

최종업데이트 2026.01.08.

Colorectal microenvironment determines the prognosis of colorectal cancer
- Exp. Mol. Med., 07 January 2026 | https://doi.org/10.1038/s12276-025-01599-7
- 2026-01
- 의약학
- 한빛사논문
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor
- J. Immunother. Cancer, Oct 31 2025, 13 (10) e012374 | https://doi.org/10.1136/jitc-2025-012374
- 2025-10
- 의약학
- 한빛사논문
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial
- J. Thorac. Oncol., Oct 19 2025, S1556-0864(25)01015-9 | https://doi.org/10.1016/j.jtho.2025.08.011
- 2025-10
- 의약학
- 한빛사논문
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in biliary tract cancer
- Clin. Cancer Res., Aug 16 2024, | https://doi.org/10.1158/1078-0432.CCR-24-1265
- 2024-08
- 의약학
- 한빛사논문
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced Non-small Cell Lung Cancer
- J. Thorac. Oncol., Published: April 05, 2023 | https://doi.org/10.1016/j.jtho.2023.03.024
- 2023-04
- 의약학
- 한빛사논문

연구자 ID

저자논문